Respiratory syncytial virus infection in childhood: a follow-up of children hospitalised for wheezing in infancy Source: Eur Respir J 2003; 22: Suppl. 45, 141s Year: 2003
Increased concordance of severe respiratory syncytial virus infection within identical twins Source: Eur Respir J 2007; 30: Suppl. 51, 399s Year: 2007
Premorbid lung function, respiratory syncytial virus infection and chronic respiratory morbidity in prematurely born infants Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005
Prevalence of respiratory syncytial virus (RSV) hospitalisation, and subsequent airway symptoms in late preterm infants Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008
Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Interleukin 13 genetic polymorphism identifies children with late wheezing following respiratory syncytial virus infection Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007
Rhinovirus infections in infancy and early childhood Source: Eur Respir J 2013; 41: 443-452 Year: 2013
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants Source: Eur Respir J 2014; 44: 666-674 Year: 2014
Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors Source: Eur Respir J 2005; 26: Suppl. 49, 628s Year: 2005
Palivizumab prophylaxis, respiratory syncytial virus and subsequent recurrent wheezing: a 2-year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 758s Year: 2006
Efficacy and safety of palivizumab in preterm infants 29-32 weeks gestational age without chronic lung disease to prevent serious respiratory syncytial virus respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 531s Year: 2002
Are infants with respiratory syncytial virus (RSV) bronchiolitis different from infants with non RSV bronchiolitis for the development of wheezing in the first year of life? Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005
Age-related pattern of childhood lung infection and its complications Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189 Year: 2002
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life Source: Eur Respir J 2002; 20: 1277-1283 Year: 2002
Epidemiology of respiratory infection in children Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children Year: 2005
Phenotype of acute respiratory syncytial virus lower respiratory tract illness in infancy and subsequent morbidity Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004
Severity of respiratory syncytial virus bronchiolitis is increased in children with passive smoking exposure. Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017
Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity Source: Annual Congress 2006 - Virus-induced respiratory tract infection Year: 2006
Risk factors for respiratory syncytial virus (RSV) related hospitalization in preterm infants: A Dutch birth cohort study Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010